Sett Pouches Review: What Ceretine Actually Is

Sett Pouches Review: What Ceretine Actually Is

Sett pouches are nicotine-free-labeled oral pouches that pair 3, 6, or 9 mg of a proprietary compound called Ceretine with 80 mg of L-theanine, at roughly $0.67 per pouch. Independent lab testing tells a different story than the label. A 2026 case series in JAMA Network Open identified Ceretine as (S)-6-methylnicotine, a nicotine analog that acts on the same receptors as nicotine, has greater pharmacologic potency, and lacks clinical research to inform safe human doses. Lab-measured 6-methylnicotine content was roughly 10% of the labeled Ceretine dose, and every Sett pouch tested contained trace nicotine.

The short verdict: Sett is built to feel like nicotine, so treat it like nicotine.

Key Takeaways

• Ceretine is 6-methylnicotine, a nicotine analog first explored by tobacco companies in the 1980s. It binds to nicotinic acetylcholine receptors and is more potent than nicotine in some assays.
• Lab-measured doses are far below the label. JAMA Network Open found 0.31 to 0.61 mg of 6-methylnicotine in pouches labeled 3 or 6 mg Ceretine, plus 0.04 to 0.06 mg of nicotine.
• No FDA authorization. Nicotine analog pouches sit outside FDA's current tobacco framework. Indiana has banned their sale outright.
• Sett is honest about one thing: the site says "this product may be addictive" and acknowledges Ceretine acts on the same receptors as nicotine.

Sett vs. the Pouches Its Buyers Compare It To

All data below is from brand product pages, labels and FDA records, checked October 7, 2026.

What Is in a Sett Pouch?

Each Sett pouch contains a stated dose of Ceretine (3, 6, or 9 mg) paired with 80 mg of L-theanine. Sett's own dosage guide maps the strengths to use patterns: 3 mg for "occasional use, subtle lift," 6 mg for "regular use, multiple pouches a day" (with the note "Zyn 6mg users: this is it"), and 9 mg labeled "High Strength" for heavier users.

Flavors include Mint, Wintergreen, Blood Orange, Raspberry Lemon, Neutral, and a Variety pack. Ingredient lists vary by SKU: some (Wintergreen 3 mg, Raspberry Lemon 3/6 mg) contain sucralose and propylene glycol, while others use xylitol and Onosweet (Reb M). Sett says it is transitioning all flavors away from artificial sweeteners.

The pouches are made in the USA, Sweden, and Denmark. Sett claims neutral pH, instructs users to keep a pouch in for 20 to 40 minutes, and says effects start within 5 to 10 minutes.

What Is Ceretine?

Sett's FAQ describes Ceretine as "a proprietary, patented ingredient designed to deliver the same satisfaction as nicotine with fewer downsides" and "a synthetic alkaloid derived from nicotine acids (b-vitamins)." The company says it "binds to nicotinic-acetylcholine receptors (nAChRs)" and "traces its roots back to the 1980s, when major tobacco companies quietly explored nicotine alternatives."

That origin story checks out. Tobacco companies, including Philip Morris, researched nicotine analogs in the 1970s and 1980s. The compound was shelved, then resurfaced decades later in disposable vapes under the trade name "Metatine" and eventually in oral pouches.

The independent data is unambiguous. Ciancio et al. (2026) tested 15 pouch products from five brands at Johns Hopkins and Roswell Park. Every Sett pouch tested contained (S)-6-methylnicotine. Specific findings for Sett:

• Wintergreen 6 mg labeled: 0.61 mg 6-methylnicotine detected, 0.04 mg nicotine, label accuracy 10.2%
• Lemon 6 mg: 0.57 mg detected, 0.06 mg nicotine, label accuracy 9.5%
• Wintergreen 3 mg: 0.31 mg detected, 0.05 mg nicotine, label accuracy 10.3%
• Lemon 3 mg: 0.31 mg detected, 0.05 mg nicotine, label accuracy 10.3%

The study described 6-methylnicotine as having "greater pharmacologic potency than nicotine" and "lacking clinical research to inform doses safe for human consumption." Truth Initiative, a tobacco-control advocacy organization, states plainly: "There is no evidence that 6-methyl-nicotine is less addictive or safer than nicotine."

A caveat: the labeled "6 mg Ceretine" may express a different salt or form than the free base that the lab quantified, so the roughly 10% label-accuracy figure is the study's finding, not necessarily proof of intentional mislabeling.

Is Sett Safe?

The honest answer: there is not enough data to say.

Sett reports it conducted in vitro and in vivo toxicity testing, receptor-binding studies, and that Ceretine showed "a toxicity profile comparable to nicotine" with lower affinity at the alpha-6 receptor subtype. The company's product page states that "Sett has been clinically tested and proven safe and effective." We could not find any of these studies published in a peer-reviewed journal.

What is published paints a more cautious picture. Xie et al. (2025) in Toxicological Sciences characterized 6-methylnicotine's metabolic pathways in mice (via intraperitoneal injection and inhalation) and in humans who inhaled SPREE BAR vapor. The study reported that mice showed acute neurotoxic signs at 6-methylnicotine doses where equimolar nicotine did not produce them. It was not designed as a safety study, involved different routes of exposure than an oral pouch, and is the only independent animal data we found.

For balance: Smith et al. (2026) in Toxicology Reports, an industry-funded study of a different manufacturer's (S)-6-methylnicotine formulation (Nixodine-S), not Sett's product, found lower potency than nicotine at one receptor subtype, with negative Ames and micronucleus assays.

Sett's own site carries a footer warning: "This product may be addictive." The FAQ acknowledges that "because Ceretine acts on the same receptors as nicotine, it carries some potential for dependence." That candor is more than some brands offer. But candor is not the same as evidence of safety. Nicotine analogs with higher potency can carry similar or greater risks at lower absolute doses, so understanding signs of nicotine overdose matters here too.

Does Sett Contain Nicotine?

Sett's site footer states: "Our products are manufactured in a facility that also produces nicotine products and may contain trace amounts. No nicotine is intentionally added."

The JAMA data tells a more specific story. Every Sett pouch tested contained 0.04 to 0.06 mg of nicotine. No other brand's analog pouches in the study contained detectable nicotine. The study's authors wrote: "All Sett pouches contained nicotine, contradicting claims of being nicotine free." Whether this comes from the manufacturing facility, as Sett suggests, or from the synthesis process, the lab found it.

Sett Pouches: Price and Where to Buy

Sett sells exclusively through getsett.co. We found no verified retail stores or Amazon listings as of October 2026.

Shipping runs about $13 to California, where an adult signature is required. Shipping is free on first subscription orders and on one-time orders over $55. Sett ships to all U.S. states except Indiana, which banned the sale of products made with nicotine analogs. California's DOJ lists Sett on its Unflavored Tobacco List as a "Portioned Analog Product."

Sett offers a 30-day satisfaction guarantee. All purchases are restricted to adults 21 and older.

Sorting Signal from Marketing

Sett occupies a strange position. It is more transparent about its product's mechanism than most brands in the nicotine-analog space. It warns about addiction potential. It maps its dosing guide to current nicotine pouch users, which is at least honest about the target audience.

The gap is the evidence. Lab-measured doses are about a tenth of the label claim. The only independent animal data we found showed acute neurotoxic effects in mice at 6-methylnicotine doses where equimolar nicotine produced none. No published human pharmacokinetic, safety, or dose-response study exists for Ceretine, or for any 6-methylnicotine oral pouch, that we could find. Sett reports having that data. Until it is published, the buyer is running on trust.

If you are exploring what nicotine-free pouches are or weighing ZYN alternatives, nicotine or not, the deciding question is mechanism: do you want a compound that hits nicotinic receptors, or do you want focus from something with a longer human track record?

Frequently Asked Questions

Is Ceretine the same as nicotine?

No, but it is closely related. Ceretine is a trade name for a compound that independent lab testing has identified as (S)-6-methylnicotine, a nicotine analog with a methyl group added at the 6-position of nicotine's pyridine ring. It binds to the same nicotinic acetylcholine receptors as nicotine and has shown greater potency in some pharmacological assays. Structurally distinct does not mean pharmacologically unrelated.

Is Sett addictive?

Sett's own site warns "this product may be addictive" and states that Ceretine "carries some potential for dependence" because it acts on nicotinic receptors. Truth Initiative notes there is no evidence that 6-methylnicotine is less addictive than nicotine. Treat the addiction risk as comparable to nicotine until proven otherwise.

Are Sett pouches FDA approved?

No. Sett pouches are not FDA authorized. According to Truth Initiative, nicotine analog products are not currently regulated by the FDA, because their small chemical differences from nicotine place them outside current tobacco rules. This is a regulatory gap, not a safety endorsement. Indiana has banned the sale of products made with nicotine analogs. California classifies Sett as a "Portioned Analog Product" on its Unflavored Tobacco List.

Will Sett show up on a nicotine test?

No data exists to answer this confidently. Standard nicotine tests screen for cotinine, a nicotine metabolite. Xie et al. (2025) found that 6-methylnicotine produces different metabolites (6-methylcotinine, 6-methyl-3'-hydroxycotinine) than nicotine. However, JAMA Network Open found trace nicotine (0.04 to 0.06 mg) in every Sett pouch tested. No study has tested Sett users for cotinine levels, so the question is genuinely unanswered.

How many mg of Ceretine should I start with?

Sett's own dosage guide recommends 3 mg for occasional use ("subtle lift"), 6 mg for regular use ("multiple pouches a day"), and 9 mg for heavier users currently using nicotine pouches above 6 mg. Given that lab-measured content is roughly 10% of the label, the actual 6-methylnicotine dose in a "6 mg" pouch is closer to 0.6 mg. Start low.

What is the difference between Sett and Ultra pouches?

Different mechanisms entirely. Sett uses 6-methylnicotine (Ceretine), which acts on nicotinic receptors. Ultra Focus pouches use 100 mg of enfinity paraxanthine, a caffeine metabolite, with no nicotine or nicotine analog. Ultra is designed for stimulant-type focus without nicotinic receptor activity. Sett is designed to replicate a nicotine buzz. The choice depends on whether you want receptor-level similarity to nicotine or a different pathway. For more on Ultra specifically, see our Ultra Focus pouches review.

Does Sett help you quit nicotine?

Sett's marketing targets current nicotine pouch users, but whether nicotine-free pouches help you quit is a separate question. No clinical evidence supports Sett or any nicotine analog pouch as a cessation tool. Sett is not marketed as a nicotine replacement therapy.

A Pouch That Runs on Caffeine, Not a Nicotine Receptor

The core tension with Sett is mechanism. If you wanted focus from a pouch and ended up reading about nicotine analogs, receptor binding, and unpublished tox data, you may be wondering whether there is a simpler path.

Roon runs on a different system entirely: 80 mg caffeine, 60 mg L-theanine, 25 mg methylliberine (Dynamine), and 5 mg theacrine (TeaCrine) in a zero-nicotine sublingual pouch. No nicotine analogs, no nicotinic receptor activity. Methylliberine slows caffeine's clearance: a randomized, double-blind crossover study (n=12) found that 100 mg methylliberine with 150 mg caffeine cut caffeine clearance from 41.9 to 17.1 L/hr and extended half-life from 7.2 to 15 hours, with no increase in peak concentration. That study ran 4× Roon's 25 mg methylliberine and nearly 2× its 80 mg caffeine, so the effect at Roon's dose is directional, not identical. What this means in practice: one pouch is built for a 6- to 8-hour felt window instead of coffee's 3 to 4.

Roon is a caffeine pouch, not a nicotine product and not a substitute for one. It does not hit nicotinic receptors. Caffeine builds tolerance like any caffeine source. And you should stop at least 8 hours before bed, because a longer half-life means more caffeine is still circulating at bedtime. Tins start at $9.16 on a 12-tin subscription ($0.61 per pouch), or $15.00 per tin one-time. If the goal is focus from a caffeine pouch instead of a nicotine pouch, that is what Roon is for.

Related from Roon

• Ultra Pouches Review
• Ultra Focus Pouches Review: Dosage and Side Effects
• Nicotine-Free Pouches: What to Know
• ZYN Alternatives Worth Trying in 2026

Written by Roon Team